JP2017225444A5 - - Google Patents

Download PDF

Info

Publication number
JP2017225444A5
JP2017225444A5 JP2017133655A JP2017133655A JP2017225444A5 JP 2017225444 A5 JP2017225444 A5 JP 2017225444A5 JP 2017133655 A JP2017133655 A JP 2017133655A JP 2017133655 A JP2017133655 A JP 2017133655A JP 2017225444 A5 JP2017225444 A5 JP 2017225444A5
Authority
JP
Japan
Prior art keywords
human
igf
crosslinker
modified
lysosomal enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017133655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017225444A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017225444A publication Critical patent/JP2017225444A/ja
Publication of JP2017225444A5 publication Critical patent/JP2017225444A5/ja
Pending legal-status Critical Current

Links

JP2017133655A 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 Pending JP2017225444A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161490957P 2011-05-27 2011-05-27
US61/490,957 2011-05-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014513625A Division JP6300720B2 (ja) 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Publications (2)

Publication Number Publication Date
JP2017225444A JP2017225444A (ja) 2017-12-28
JP2017225444A5 true JP2017225444A5 (cg-RX-API-DMAC10.html) 2019-06-27

Family

ID=47260229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014513625A Active JP6300720B2 (ja) 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法
JP2017133655A Pending JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014513625A Active JP6300720B2 (ja) 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Country Status (21)

Country Link
US (2) US9545450B2 (cg-RX-API-DMAC10.html)
EP (1) EP2714752B1 (cg-RX-API-DMAC10.html)
JP (2) JP6300720B2 (cg-RX-API-DMAC10.html)
KR (2) KR20190022943A (cg-RX-API-DMAC10.html)
CN (2) CN108586621A (cg-RX-API-DMAC10.html)
BR (1) BR112013030432A2 (cg-RX-API-DMAC10.html)
CA (1) CA2836318C (cg-RX-API-DMAC10.html)
CY (1) CY1120485T1 (cg-RX-API-DMAC10.html)
DK (1) DK2714752T3 (cg-RX-API-DMAC10.html)
ES (1) ES2660185T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20180291T1 (cg-RX-API-DMAC10.html)
HU (1) HUE038172T2 (cg-RX-API-DMAC10.html)
LT (1) LT2714752T (cg-RX-API-DMAC10.html)
NO (1) NO2820016T3 (cg-RX-API-DMAC10.html)
PL (1) PL2714752T3 (cg-RX-API-DMAC10.html)
PT (1) PT2714752T (cg-RX-API-DMAC10.html)
RS (1) RS56913B1 (cg-RX-API-DMAC10.html)
SI (1) SI2714752T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201800101T1 (cg-RX-API-DMAC10.html)
TR (1) TR201802230T4 (cg-RX-API-DMAC10.html)
WO (1) WO2012166653A2 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925303B2 (en) * 2012-11-13 2018-03-27 Edwards Lifesciences Corporation Methods for cross-linking bioprosthetic tissue using bio-orthogonal binding pairs
EP2976092B1 (en) 2013-03-15 2020-04-22 Amicus Therapeutics, Inc. Chemical crosslinkers
CN111233992B (zh) * 2014-04-04 2024-07-19 韦斯塔隆公司 人工活化的肽
WO2016025519A1 (en) * 2014-08-11 2016-02-18 Shire Human Genetic Therapies, Inc. Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
JP6851964B2 (ja) * 2014-09-30 2021-03-31 アミカス セラピューティックス インコーポレイテッド 炭水化物が増大している非常に強力な酸性アルファ−グルコシダーゼ
CN104356238B (zh) * 2014-10-15 2018-01-09 大连理工大学 一种重组蛋白a亲和配基的定点固定化方法
EP3268589B1 (en) * 2015-03-11 2019-06-26 OCV Intellectual Capital, LLC Methods for filling mufflers with fibrous material
HK1253529A1 (zh) 2015-11-06 2019-06-21 Biomarin Pharmaceutical Inc. 用於检测中和溶酶体酶的摄取的抗体或其它因子的基於细胞的测定
MY207684A (en) * 2015-12-08 2025-03-12 Regeneron Pharma Compositions and methods for internalizing enzymes
AU2018281280B2 (en) 2017-06-07 2024-12-19 Regeneron Pharmaceuticals, Inc. Compositions and methods for internalizing enzymes
JP7356911B2 (ja) 2017-06-14 2023-10-05 ヴァイロメティックス アーゲー 呼吸器合胞体ウイルスに対する予防のための環状ペプチド
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
CN112040985A (zh) 2018-02-07 2020-12-04 瑞泽恩制药公司 用于递送治疗性蛋白质的方法和组合物
US11492610B2 (en) 2018-03-08 2022-11-08 California Institute Of Technology Sample multiplexing for single-cell RNA sequencing
TW202344691A (zh) 2018-04-30 2023-11-16 美商阿米庫斯醫療股份有限公司 基因治療構築體及使用方法
EP3793591A1 (en) 2018-05-17 2021-03-24 Regeneron Pharmaceuticals, Inc. Anti-cd63 antibodies, conjugates, and uses thereof
JP7577650B2 (ja) 2018-10-10 2024-11-05 アミカス セラピューティックス インコーポレイテッド ジスルフィド結合により安定したポリペプチド組成物及びその使用方法
WO2020113036A2 (en) * 2018-11-28 2020-06-04 Promega Corporation Reactive peptide labeling
EP3897747A4 (en) 2018-12-19 2022-12-07 The Board of Trustees of the Leland Stanford Junior University BIFUNCTIONAL MOLECULES FOR LYSOSOMA TARGETING AND RELATED COMPOSITIONS AND METHODS
CA3121724A1 (en) 2018-12-20 2020-06-25 Virometix Ag Lipopeptide building blocks and synthetic virus-like particles
US20220193261A1 (en) * 2019-04-30 2022-06-23 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of pompe disease
CN110373405B (zh) * 2019-07-24 2023-12-15 杭州恩和生物科技有限公司 一种接枝聚合物的生物酶及其制备方法和固定方法
JP2022552254A (ja) * 2019-10-10 2022-12-15 アミカス セラピューティックス インコーポレイテッド バリアントigf2構築体
US20230355737A1 (en) 2020-09-28 2023-11-09 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination
AR124216A1 (es) 2020-12-01 2023-03-01 Univ Pennsylvania Composiciones nuevas con motivos selectivos específicos del tejido y composiciones que las contienen
AU2022262771A1 (en) 2021-04-23 2023-11-02 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
EP4359430A4 (en) 2021-06-23 2025-07-16 Lycia Therapeutics Inc BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES
JP2024524614A (ja) 2021-07-14 2024-07-05 ライシア セラピューティクス, インコーポレイテッド Asgpr細胞表面受容体結合化合物及びコンジュゲート
EP4634394A2 (en) 2022-12-17 2025-10-22 The Trustees of The University of Pennsylvania Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
WO2025007046A1 (en) 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
CN121693342A (zh) 2023-07-12 2026-03-17 维罗迈科斯股份公司 肺炎球菌抗原的组合物
KR20260114566A (ko) 2023-11-14 2026-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1118334A1 (en) * 2000-01-11 2001-07-25 Aventis Behring Gesellschaft mit beschränkter Haftung Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) * 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
US7355018B2 (en) 2003-09-30 2008-04-08 Regeneron Pharmaceuticals, Inc. Modified IGF1 polypeptides with increased stability and potency
WO2009137721A2 (en) 2008-05-07 2009-11-12 Zystor Therapeutics, Inc. Lysosomal targeting peptides and uses thereof
PL3912643T3 (pl) * 2009-02-13 2023-01-23 Immunomedics Inc. Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo

Similar Documents

Publication Publication Date Title
JP2014518063A5 (cg-RX-API-DMAC10.html)
DK2714752T3 (en) PROCEDURES FOR THE CONNECTION OF TARGETING PEPTIDES TO RECOMBINANT LYSOSOMAL ENZYMES FOR IMPROVED TREATMENT OF LYSOSOMAL DISPOSAL DISEASES
ES2909664T3 (es) Composición farmacéutica que comprende arginina desiminasa de unión a albúmina para el tratamiento dirigido del cáncer
ES2804594T3 (es) Reticuladores químicos
WO2013065009A1 (en) A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly
TW201945014A (zh) 用於治療粒線體性神經胃腸腦病變之組合物及方法
KR20100014215A (ko) 신규 단백질 접합체 및 그것의 제조 방법
JP2014506450A5 (cg-RX-API-DMAC10.html)
JP2011505164A5 (cg-RX-API-DMAC10.html)
US10632187B2 (en) Hemagglutinin-binding peptide
WO2014082080A2 (en) Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
JPS6084298A (ja) 新規生理活性ポリペプチドおよびその製造法
CN108341879A (zh) 一种嵌合多肽及其用途
JPS58203953A (ja) C末端アミド化ペプチドの前駆体およびその製造法
JP3135060B2 (ja) ヘモフィルスインフルエンザb型菌の外皮膜タンパク質P2の部分断片を用いた接合体
JP2011510043A (ja) 新規血液凝固因子インヒビター
KR20240166574A (ko) 점액점착 및 바이러스 결합 특성을 가진 2중 기능성 펩타이드
WO2026078691A1 (en) Matrix metalloproteinase inhibitors and uses thereof
JPH03123799A (ja) フィブリン結合活性ポリペプチド
TW202608914A (zh) 用於肥胖症及t2dm之人類glp1r及gipr之單促效劑及雙重促效劑化合物
TW202615456A (zh) 用於肥胖症及第二型糖尿病(t2dm)的雙重及三重促效劑化合物
Boots Covalent and non-covalent semisynthesis of cytochrome c analogues
CN110785182A (zh) 亲硅蛋白(silaffin)二氧化硅颗粒佐剂
JPH0320237B2 (cg-RX-API-DMAC10.html)
JPH05506250A (ja) エンドテリン形成の阻害